Replies to post #222 on Trillium Therapeutics Inc (TRIL)

[NY1972]

RNA-LPX triggers interferon-a (IFNa) release by plasmacytoid DCs and macrophages. Consequently, DC maturation in situ and inflammatory immune mechanisms reminiscent of those in the early systemic phase of viral infection are activated.

http://www.nature.com/nature/journal/vaop/ncurrent/full/nature18300.html